Generic Transition Strategy Delivers Significant Pharmacy Savings
The Challenge
Plan members were utilizing Farxiga through Personal Importation to reduce high retail costs.
With the recent introduction of a generic, dapagliflozin, the existing strategy required re-evaluation to determine the most cost-effective sourcing option and capture additional savings.
Our Solution
OneVeracity implemented a targeted pharmacy optimization strategy to transition members to the most cost-effective clinically appropriate option while maintaining continuity of care, including:
- Condition-based review of members utilizing Farxiga
- Evaluation of lowest-cost sourcing channels (Retail, Personal Importation, Mark Cuban Cost Plus Drug Company, PBC)
- Coordination of member transitions from Personal Importation to Cost Plus Drug where appropriate
This approach ensured members maintained therapy while unlocking additional savings through a lower-cost dispensing channel.
Our Impact
This initiative demonstrates how proactive pharmacy management and sourcing optimization can reduce costs beyond traditional importation strategies.
Farxiga 10mg (90-day supply):
- Retail Pharmacy: $1,142.52
- Personal Importation: $383.61
- Annual Savings via Personal Importation: $3,035.64
Dapagliflozin 10mg (90-day supply):
- Retail Pharmacy: $510.06 to $1,084.70
- Cost Plus Drug: $15.07
Savings Achieved:
- Estimated Annual Retail Savings: $1,979.96 to $4,278.52
- Additional Annual Savings vs Personal Importation: $1,474.16
- Total Estimated Annual Savings: $3,454.12 to $5,752.68
Key Outcomes
- Significant incremental savings beyond Personal Importation sourcing
- Seamless transition to generic equivalent medication
- Maintained continuity of care with clinically appropriate therapy
- Reduced long-term pharmacy spend through proactive intervention
By continuously evaluating market changes and sourcing options, OneVeracity identifies new opportunities to lower pharmacy costs. The transition from brand to generic, combined with optimized dispensing channels, delivers measurable savings while preserving quality of care.
